Compare ETB & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Eaton Vance Tax-Managed Buy-Write Income Fund Eaton Vance Tax-Managed Buy-Write Income Fund of Beneficial Interest
Current Price
| Metric | ETB | EMBC |
|---|---|---|
| Founded | N/A | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.4M | 521.7M |
| IPO Year | 2004 | 2021 |
| Metric | ETB | EMBC |
|---|---|---|
| Price | $14.82 | $8.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 43.5K | ★ 740.3K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | ★ 6.77% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.03 | $8.72 |
| 52 Week High | $15.60 | $15.55 |
| Indicator | ETB | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 35.00 | 33.97 |
| Support Level | $14.73 | N/A |
| Resistance Level | $15.04 | $10.88 |
| Average True Range (ATR) | 0.20 | 0.30 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 0.74 | 11.49 |
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.